We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Anna is a senior science editor at Technology Networks. She holds a first-class honours degree in biological sciences from the University of East Anglia, before joining Technology Networks she helped organize scientific conferences.
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Cells are exceptionally good at responding and adapting to their environment. To do this, they must be able to receive and process “signals” that originate outside of the cell. However, in cancer, genetic and/or epigenetic changes can occur within a cell or group of cells, which disrupts their normal functioning. Many of these disruptions map to specific cell signaling pathways.
Download this infographic to explore:
The relationship between cell signaling and cancer
What happens when signaling goes wrong
How critical mediators of abnormal signaling can be therapeutically targeted
Anna is a senior science editor at Technology Networks. She holds a first-class honours degree in biological sciences from the University of East Anglia, before joining Technology Networks she helped organize scientific conferences.
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.